Adage Capital Partners GP »

Ocuphire Pharma shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 955k 1.65

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
ConocoPhillips (COP)
Visa Com Cl A (V)

View all positions for Adage Capital Partners GP

Top funds holding Ocuphire Pharma

Perceptive Advisors
BIOS Capital Management
Nantahala Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Voss Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Creative Planning
Citadel Advisors
Two Sigma Investments

View all funds holding Ocuphire Pharma